Seventure Partners
Overview
Seventure Partners is a leading European venture capital firm seeking to fund innovation among digital technology and life science companies. With more than 250 companies funded since 1997, Seventure Partners is deeply involved in the creation of economic wealth and technological development, particularly in France and Europe. Seventure Partners is a long-term equity investor dedicated to supporting innovative companies that generate positive impacts on humankind, society, sustainability, and the planet.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mediads | May 2026 | Seed | Lead |
| Bel Group | Mar 2026 | Series B | Co-investor |
| Standing Ovation | Mar 2026 | Series B | Co-investor |
| Kainova Therapeutics | Feb 2026 | Series B | Co-investor |
| ErVimmune | Jan 2026 | Series A | Co-investor |
Key People
David Manjarres
Head Of ICT Department - General Partner
Annegret de Baey-Diepolder
Venture Partner
Mathieu Kayser
Venture Partner
Nora Frey
Venture Partner
Oxana Kukhaneva
Venture Partner
Pascal Pierra
Venture Partner
Philippe Tramoy
Partner
Pierre Erwes
Partner - Deal Flow Strategic Partnerships
Guillaume Echaudemaison
Senior Associate VC Investor
Arthur Bourgade
Venture Capital Associate Sportech Life Sciences
Quang Lê
Senior Associate - Venture Capital Growth Equity
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.